Angiomatoid Fibrous Histiocytoma

specific

A low malignant potential soft tissue neoplasm of uncertain differentiation. It typically affects young patients, presenting as a slowly growing nodular or cystic tumor mass, most often in the subcutaneous tissues of the extremities. Occasionally, patients have systemic symptoms (anemia, fever, and weight loss). This tumor has a relatively good prognosis. A minority of patients develop local recurrences. Metastases are rare.

69

Centers

73

Active Trials

Cancer Funding

Top Centers for Angiomatoid Fibrous Histiocytoma(69)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.6
2
High-Volume Research Center
71.6
3
High-Volume Research Center
71.6
4
High-Volume Research Center
71.6
5
High-Volume Research Center
71.6
6
NCI Comprehensive
Active Research Program
49.4
7
NCI Comprehensive
Active Research Program
49.4
8
NCI Comprehensive
Active Research Program
49.4
9
NCI Comprehensive
Active Research Program
49.4
10
NCI Comprehensive
Active Research Program
49.4
11
NCI Comprehensive
Active Research Program
49.4
12
NCI Comprehensive
Active Research Program
49.4
13
NCI Comprehensive
Active Research Program
49.4
14
NCI Comprehensive
Active Research Program
49.4
15
NCI Comprehensive
Active Research Program
49.4
16
NCI Comprehensive
Active Research Program
49.4
17
NCI Comprehensive
Active Research Program
49.4
18
NCI Comprehensive
Active Research Program
49.4
19
NCI Comprehensive
Active Research Program
49.4
20
NCI Comprehensive
Active Research Program
49.4
21
NCI Comprehensive
Active Research Program
49.4
2249.4
23
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
49.4
24
NCI Comprehensive
Active Research Program
49.4
25
NCI Comprehensive
Active Research Program
49.4
26
NCI Comprehensive
Active Research Program
49.4
27
NCI Comprehensive
Active Research Program
49.4
28
NCI Comprehensive
Active Research Program
49.4
29
NCI Comprehensive
Active Research Program
49.4
30
NCI Comprehensive
Active Research Program
49.4
31
NCI Comprehensive
Active Research Program
49.4
32
NCI Clinical
Active Research Program
49.4
33
NCI Comprehensive
Active Research Program
49.4
34
NCI Comprehensive
Active Research Program
49.4
35
NCI Comprehensive
Active Research Program
49.4
36
NCI Comprehensive
Active Research Program
49.4
37
NCI Clinical
Active Research Program
49.4
38
NCI Comprehensive
Active Research Program
49.4
39
Active Research Program
49.4
40
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
49.4
41
NCI Comprehensive
Active Research Program
49.4
42
Active Research Program
49.4
43
Active Research Program
49.4
44
NCI Comprehensive
Active Research Program
49.4
45
NCI Comprehensive
Active Research Program
49.4
46
NCI Clinical
Active Research Program
49.4
47
NCI Comprehensive
Active Research Program
49.4
48
NCI Comprehensive
Active Research Program
49.4
49
NCI Comprehensive
Active Research Program
49.4
50
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
49.4
51
NCI Clinical
Active Research Program
49.4
52
NCI Comprehensive
Active Research Program
49.4
53
Active Research Program
49.4
54
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
49.4
55
NCI Comprehensive
Active Research Program
49.4
5649.4
57
Active Research Program
49.4
58
Active Research Program
49.4
59
Active Research Program
49.4
60
Active Research Program
49.4
61
Active Research Program
49.4
62
Active Research Program
49.4
63
Active Research Program
49.4
6449.4
65
Active Research Program
49.4
66
Active Research Program
49.4
67
BC CancerVancouver, BC
Active Research Program
49.4
68
Active Research Program
49.4
69
NCI Comprehensive
28.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →